CLOV
Price
$4.88Alerts
Change
-$0.09 (-1.81%)
Updated
Nov 12 closing price
Capitalization
2.56B
112 days until earnings call
Intraday BUY SELL Signals
OSCR
Price
$31.94Alerts
Change
-$0.17 (-0.53%)
Updated
Nov 12, 04:59 PM (EDT)
Capitalization
9.46B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLOV vs OSCR

CLOV vs OSCR Comparison Chart in %
View a ticker or compare two or three
VS
CLOV vs. OSCR commentary
Nov 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a Buy and OSCR is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CLOV with price predictions
Nov 11, 2026

CLOV's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CLOV turned positive on November 09, 2026. Looking at past instances where CLOV's MACD turned positive, the stock continued to rise in 40 of 47 cases over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 56 cases where CLOV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on CLOV as a result. In 60 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

CLOV moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLOV advanced for three days, in 225 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

CLOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLOV's P/B Ratio (6.804) is slightly higher than the industry average of (3.520). P/E Ratio (-120.500) is within average values for comparable stocks, (126.353). CLOV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.970) is also within normal values, averaging (0.569).

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating fairly steady price growth. CLOV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

A.I.Advisor
a Summary for OSCR with price predictions
Nov 11, 2026

OSCR in upward trend: 10-day moving average crossed above 50-day moving average on November 10, 2026

The 10-day moving average for OSCR crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 19 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 58 cases where OSCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on OSCR as a result. In 60 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for OSCR just turned positive on November 10, 2026. Looking at past instances where OSCR's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.

OSCR moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +9.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where OSCR advanced for three days, in 234 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 164 of 225 cases where OSCR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OSCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

OSCR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 31 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating fairly steady price growth. OSCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.610) is normal, around the industry mean (3.520). P/E Ratio (19.277) is within average values for comparable stocks, (126.353). OSCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.618) is also within normal values, averaging (0.569).

FUNDAMENTALS RATINGS
CLOV: Fundamental Ratings
CLOV
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
55
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLOVOSCR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
70%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
COMPARISON
Comparison
Nov 13, 2026
Stock price -- (CLOV: $4.97 vs. OSCR: $32.11)
Brand notoriety: CLOV and OSCR are both not notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: CLOV: 90% vs. OSCR: 67%
Market capitalization -- CLOV: $2.56B vs. OSCR: $9.46B
CLOV [@Managed Health Care] is valued at $2.56B. OSCR’s [@Managed Health Care] market capitalization is $9.46B. The market cap for tickers in the [@Managed Health Care] industry ranges from $335.99K to $353.79B. The average market capitalization across the [@Managed Health Care] industry is $67.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLOV’s FA Score shows that 1 FA rating(s) are green while OSCR’s FA Score has 1 green FA rating(s).

  • CLOV’s FA Score: 1 green, 4 red.
  • OSCR’s FA Score: 1 green, 4 red.
According to our system of comparison, OSCR is a better buy in the long-term than CLOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLOV’s TA Score shows that 6 TA indicator(s) are bullish while OSCR’s TA Score has 7 bullish TA indicator(s).

  • CLOV’s TA Score: 6 bullish, 1 bearish.
  • OSCR’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, both CLOV and OSCR are a good buy in the short-term.

Price Growth

CLOV (@Managed Health Care) experienced а +5.97% price change this week, while OSCR (@Managed Health Care) price change was -8.75% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was +1.93%. For the same industry, the average monthly price growth was +4.07%, and the average quarterly price growth was +16.14%.

Reported Earning Dates

CLOV is expected to report earnings on Mar 04, 2027.

OSCR is expected to report earnings on Feb 11, 2027.

Industries' Descriptions

@Managed Health Care (+1.93% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

View a ticker or compare two or three
Interact to see
Advertisement

CLOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLOV has been loosely correlated with ALHC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CLOV jumps, then ALHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLOV
1D Price
Change %
CLOV100%
+0.81%
ALHC - CLOV
39%
Loosely correlated
+0.26%
OSCR - CLOV
35%
Loosely correlated
-4.06%
PGNY - CLOV
23%
Poorly correlated
+0.19%
HUM - CLOV
6%
Poorly correlated
+1.88%
MOH - CLOV
4%
Poorly correlated
+1.41%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
USLV9.590.08
+0.84%
Direxion Daily Silver Bull 2X ETF (USLV)
ZALT34.680.18
+0.52%
Innovator U.S. Equity 10 Buffer ETF - Quarterly (ZALT)
USHY35.700.05
+0.14%
iShares Broad USD High Yield Corporate Bond ETF (USHY)
EPRF15.48-0.04
-0.27%
Innovator S&P Investment Grade Preferred ETF (EPRF)
DBP89.65-0.62
-0.69%
Invesco DB Precious Metals Fund (DBP)